Wag Group Co Stock Performance
| PET Stock | USD 0.26 0.01 3.70% |
The firm maintains a market beta of 1.37, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Wag Group will likely underperform. At this point, Wag Group has a negative expected return of -0.83%. Please make sure to check out Wag Group's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Wag Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Wag Group Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | TD Securities Lowers Pet Valu Price Target to C30.00 | 11/06/2024 |
2 | Disposition of 16727 shares by Adam Storm of Wag Group at 0.17 subject to Rule 16b-3 | 11/19/2024 |
3 | MID AMERICA PET FOOD APPOINTS NEW CHIEF MARKETING OFFICER | 11/20/2024 |
4 | Cold and Creaky truInsights into How Winter Weather Impacts our Pets | 12/04/2024 |
5 | Disposition of 7485 shares by Garrett Smallwood of Wag Group at 1.49 subject to Rule 16b-3 | 12/05/2024 |
6 | Reviewers Say This Shark Is So Good, You Will Never Want Another Vacuum. Its 50 percent Off At Walmart Right Now. | 12/12/2024 |
7 | Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography Trial of PIPE-791 | 12/16/2024 |
8 | Considering delayed non-dilutive sources of financing, CARBIOS postpones construction of its Longlaville PET biorecycling plant for 6 to 9 months | 12/19/2024 |
9 | Disposition of 2480 shares by Dylan Allread of Wag Group at 1.57 subject to Rule 16b-3 | 12/24/2024 |
10 | Wag Group Co. Stock Catapults 27 percent Though Its Price And Business Still Lag The Industry | 01/03/2025 |
11 | PAW PROSPER STRENGTHENS ITS COMMITMENT TO PET WELL-BEING WITH THE ACQUISITION OF SLEEPYPOD GLOBAL-LEADER IN CRASH-TEST-CERTIFIED SAFETY HARNESSES AND CARRIERS | 01/07/2025 |
12 | Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04 | 01/17/2025 |
| Begin Period Cash Flow | 39 M |
Wag |
Wag Group Relative Risk vs. Return Landscape
If you would invest 82.00 in Wag Group Co on October 20, 2024 and sell it today you would lose (56.00) from holding Wag Group Co or give up 68.29% of portfolio value over 90 days. Wag Group Co is generating negative expected returns assuming volatility of 11.6121% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Wag, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Wag Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wag Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Wag Group Co, and traders can use it to determine the average amount a Wag Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0711
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PET |
Estimated Market Risk
| 11.61 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.83 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Wag Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wag Group by adding Wag Group to a well-diversified portfolio.
Wag Group Fundamentals Growth
Wag Stock prices reflect investors' perceptions of the future prospects and financial health of Wag Group, and Wag Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wag Stock performance.
| Return On Equity | -7.46 | ||||
| Return On Asset | -0.0637 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 24.3 M | ||||
| Shares Outstanding | 48.81 M | ||||
| Price To Book | 5.38 X | ||||
| Price To Sales | 0.17 X | ||||
| Revenue | 83.92 M | ||||
| Gross Profit | 39.82 M | ||||
| EBITDA | (4.69 M) | ||||
| Net Income | (13.32 M) | ||||
| Cash And Equivalents | 9.4 M | ||||
| Cash Per Share | 1.49 X | ||||
| Total Debt | 28.62 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | (6.46 M) | ||||
| Earnings Per Share | (0.31) X | ||||
| Market Capitalization | 32.01 M | ||||
| Total Asset | 46.7 M | ||||
| Retained Earnings | (161.73 M) | ||||
| Working Capital | 13.38 M | ||||
About Wag Group Performance
Assessing Wag Group's fundamental ratios provides investors with valuable insights into Wag Group's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Wag Group is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 110.01 | 115.51 | |
| Return On Tangible Assets | (0.36) | (0.38) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.26) | (0.27) | |
| Return On Equity | (9.30) | (8.84) |
Things to note about Wag Group performance evaluation
Checking the ongoing alerts about Wag Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Wag Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wag Group generated a negative expected return over the last 90 days | |
| Wag Group has high historical volatility and very poor performance | |
| Wag Group has some characteristics of a very speculative penny stock | |
| Wag Group has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 83.92 M. Reported Net Loss for the year was (13.32 M) with profit before taxes, overhead, and interest of 39.82 M. | |
| Wag Group Co has about 9.4 M in cash with (6.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Wag Group has a poor financial position based on the latest SEC disclosures | |
| Roughly 56.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04 |
- Analyzing Wag Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wag Group's stock is overvalued or undervalued compared to its peers.
- Examining Wag Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wag Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wag Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wag Group's stock. These opinions can provide insight into Wag Group's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Wag Stock Analysis
When running Wag Group's price analysis, check to measure Wag Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wag Group is operating at the current time. Most of Wag Group's value examination focuses on studying past and present price action to predict the probability of Wag Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wag Group's price. Additionally, you may evaluate how the addition of Wag Group to your portfolios can decrease your overall portfolio volatility.